Post-TARE Survival Outcomes in Hepatocellular Carcinoma: Influence of Pre-TARE Immunotherapy and Targeted Therapy in a Real-World Cohort

In this real-world cohort, treatment exposure prior to TARE was associated with post-TARE PFS and tumor response, but not with OS. These findings suggest that baseline treatment history and systemic inflammatory status influence post-TARE prognosis, rather than indicating the superiority of a specific treatment sequence. Prospective studies with longer follow-up are warranted.